The All Ordinaries Index (ASX: XAO) slid down close to a percent today, with the healthcare sector doing the same. At the time of writing, the All Ords is down 0.96% and the healthcare sector has dipped 1.2%.
Regardless of this lacklustre performance, these 2 ASX healthcare shares are having a pretty good day.
Image source: Getty Images
Anteris Technologies Ltd (ASX: AVR)
The Anteris share price has surged 18.60% today to reach $5.10 per share. This gain comes after a tough year, with the Anteris share price dropping more than 62% over the past 12 months.
The company's mission is to create the world's most durable heart valve. While no significant news hit the wires today, the company continues to steadily progress its heart valve technology.
In March 2020, Anteris announced the first implantation of its ADAPT-treated single-piece 3D aortic valve in a patient with aortic stenosis.
At the start of this year, the company confirmed that it had entered into a short-term facility for a $1,220,000 advance, based on its forecasted research & development (R&D) tax incentive. Anteris followed this statement up two days later announcing an additional $20 million in secured funding.
According to Anteris, the company continues to focus on delivering "next generation technologies that help healthcare professionals create life-changing outcomes for patients."
CleanSpace Holdings Ltd (ASX: CSX)
The CleanSpace Holdings share price is currently up by 7.29%, trading at $7.51 at the time of writing. The company engages in the design and manufacturing of respiratory protection equipment (RPE) for healthcare and industrial employers internationally.
The purpose of RPE is to protect people from inhaling hazardous substances in the air. The Sydney-based company was founded by a team of biomedical engineers in 2009. Products sold by CleanSpace include the CleanSpace Halo for the healthcare market and the CleanSpace2, CleanSpace Ultra and CleanSpace Ex designed for industrial markets.
While it's been a rocky ride over the previous 12-month period, the CleanSpace share price has just managed to inch into the green, returning 0.67% over the past year.
In its most recent trading update, CleanSpace upgraded its first half FY21 revenue expectations to be in the range of $39 million–$41 million for the six months ended 31 December 2020.
